ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,463,000 | +609.5% | 358,800 | +321.1% | 0.11% | +286.2% |
| Q2 2016 | $629,000 | -1.1% | 85,200 | -14.5% | 0.03% | -6.5% |
| Q1 2016 | $636,000 | +69.6% | 99,600 | +65.7% | 0.03% | +34.8% |
| Q4 2015 | $375,000 | -72.9% | 60,100 | -74.6% | 0.02% | -77.9% |
| Q3 2015 | $1,383,000 | +178.3% | 236,900 | +292.2% | 0.10% | +116.7% |
| Q1 2015 | $497,000 | +48.4% | 60,400 | +23.5% | 0.05% | -7.7% |
| Q4 2014 | $335,000 | -68.1% | 48,900 | -14.4% | 0.05% | -44.7% |
| Q3 2013 | $1,050,000 | – | 57,100 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |